泰昆蛋白 (874257.OC)

+ 收藏

现金流量表(泰昆蛋白)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报
上市前/上市后 上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 1,380,526,848.913,624,784,609.952,819,394,664.951,885,739,023.77
 收到的税费返还(元) 79,472.93401,812.95367,503.29299,095.77
 收到其他与经营活动有关的现金(元) 13,307,926.9714,771,775.3113,757,271.674,257,510.59
 经营活动现金流入小计(元) 1,393,914,248.813,639,958,198.212,833,519,439.911,890,295,630.13
 购买商品、接受劳务支付的现金(元) 1,440,299,569.183,047,143,706.181,924,585,533.351,506,008,822.36
 支付给职工以及为职工支付的现金(元) 29,258,274.3557,258,326.6438,467,413.7826,319,535.03
 支付的各项税费(元) 6,894,784.0913,924,193.1412,805,139.0410,925,414.74
 支付其他与经营活动有关的现金(元) 14,506,563.7321,760,368.2418,023,856.847,262,240.42
 经营活动现金流出小计(元) 1,490,959,191.353,140,086,594.201,993,881,943.011,550,516,012.55
 经营活动产生的现金流量净额(元) -97,044,942.54499,871,604.01839,637,496.90339,779,617.58
二、投资活动产生的现金流量
 收回投资收到的现金(元) 25,533,932.4432,633,692.1029,486,745.0028,747,285.00
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -90,608.4030,936.8059,624.00
 投资活动现金流入小计(元) 25,533,932.4432,724,300.5029,517,681.8028,806,909.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 33,045,514.1292,028,172.2154,577,765.238,500,854.44
 投资支付的现金(元) 15,500,000.0016,700,000.003,500,000.003,050,000.00
 投资活动现金流出小计(元) 48,545,514.12108,728,172.2158,077,765.2311,550,854.44
 投资活动产生的现金流量净额(元) -23,011,581.68-76,003,871.71-28,560,083.4317,256,054.56
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 572,188,846.18965,522,598.40370,192,478.40251,608,731.80
 收到其他与筹资活动有关的现金(元) -431,258,405.46431,864,405.46431,258,405.46
 筹资活动现金流入小计(元) 572,188,846.181,396,781,003.86802,056,883.86682,867,137.26
 偿还债务支付的现金(元) 425,792,202.60528,192,938.40302,325,478.4050,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 48,292,130.2156,309,309.3854,398,627.4937,581,594.85
  其中:子公司支付给少数股东的股利、利润(元) -13,654,194.15--
 支付其他与筹资活动有关的现金(元) 700,000.001,109,826,774.091,109,732,774.09901,959,097.75
 筹资活动现金流出小计(元) 474,784,332.811,694,329,021.871,466,456,879.98989,540,692.60
 筹资活动产生的现金流量净额(元) 97,404,513.37-297,548,018.01-664,399,996.12-306,673,555.34
五、现金及现金等价物净增加额(元) -22,652,010.85126,319,714.29146,677,417.3550,362,116.80
 加:期初现金及现金等价物余额(元) 153,875,155.2827,555,440.9927,555,440.9927,555,440.99
 期末现金及现金等价物余额(元) 131,223,144.43153,875,155.28174,232,858.3477,917,557.79
补充资料:
 净利润(元) 5,030,110.67122,361,144.57-71,639,804.62
 资产减值准备(元) 805,913.947,950,689.05--
 固定资产和投资性房地产折旧(元) 11,099,252.2621,555,459.80-10,777,729.90
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 11,099,252.2621,555,459.80-10,777,729.90
 无形资产摊销(元) 998,433.181,562,294.84-781,147.42
 长期待摊费用摊销(元) 49,768.5099,536.76-49,768.38
 处置固定资产、无形资产和其他长期资产的损失(元) ----121,265.79
 固定资产报废损失(元) 161,071.94408,598.85-344,385.82
 公允价值变动损失(元) 2,449,700.00-5,259,640.00--1,912,180.00
 财务费用(元) 8,378,687.1918,962,865.80-14,112,262.76
 投资损失(元) -3,613,535.09-4,330,862.54--3,838,709.82
 递延所得税(元) 1,209,870.78113,688.92--48,767.34
  其中:递延所得税资产减少(元) 1,575,641.45-1,093,768.94--
 递延所得税负债增加(元) -365,770.671,207,457.86--48,767.34
 存货的减少(元) -176,199,606.86185,951,858.91-48,003,048.89
 经营性应收项目的减少(元) 50,559,853.60222,138,133.03-268,067,126.23
 经营性应付项目的增加(元) 1,770,119.87-71,971,154.25--68,040,536.53
 现金的期末余额(元) 131,223,144.43153,875,155.28-77,917,557.79
 减:现金的期初余额(元) 153,875,155.2827,555,440.99-27,555,440.99
 现金及现金等价物的净增加额(元) -22,652,010.85126,319,714.29-50,362,116.80
公告日期 2024-08-232024-03-292023-11-212024-08-23
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院